U.S. government funds Moderna $176m for accelerating bird flu (H5N1) mRNA vaccine development.

The U.S. government is providing Moderna $176 million to accelerate the development of an mRNA pandemic flu vaccine targeting bird flu (H5N1). The funding aims to advance research and potentially offer a solution to future influenza pandemics. Moderna's mRNA vaccine candidate is currently in early-stage testing, using the same technology that enabled rapid development and rollout of COVID-19 vaccines.

July 02, 2024
129 Articles